# Edwards Lifesciences

Organization · id `cardio:edwards-lifesciences` · Cardiovascular Atlas · release `f6f6f1b6f50379ed` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Edwards Lifesciences, LLC

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A company based in the United States (ROR types: company and funder). US regulatory records name Edwards Lifesciences, LLC as the applicant for the approval of the SAPIEN 3 heart valve. ClinicalTrials.gov names Edwards Lifesciences as the lead sponsor of PARTNER 3 and EARLY TAVR, and the PubMed abstracts of both trials say Edwards Lifesciences funded them.

## Technical summary

Research Organization Registry record 04jhyte11, named Edwards Lifesciences (United States), type company and funder. openFDA PMA P140031 names Edwards Lifesciences, LLC as the applicant. The registry names Edwards Lifesciences, class industry, as lead sponsor of NCT02675114 and NCT03042104. The registry name carries no LLC; the sources read do not say how the two names relate, and this atlas does not say.

## Connected pages

- Manufactures: SAPIEN 3 transcatheter heart valve (`cardio:sapien-3`)
- Sponsors: EARLY TAVR (`cardio:early-tavr`)
- Funds: EARLY TAVR (`cardio:early-tavr`)
- Sponsors: PARTNER 3 trial (`cardio:partner-3`)
- Funds: PARTNER 3 trial (`cardio:partner-3`)

## Provenance

Content hash: 3109914e8b8e90e67d6ac345e7c4e884bb7d2c1d29d68982d59df1f7cbf72c2c
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-14